Buscar
AbbVie Inc
ABBVAñadir a la lista de seguimiento
234.760USD
+4.750+2.07%
Cierre 06/23, 16:00（ET）Cotizaciones retrasadas 15 min
414.77BCap. mercado
115.55P/E TTM
Más Datos de AbbVie Inc Compañía
AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its investigational candidate, bretisilocin, is for the treatment of patients with moderate-to-severe major depressive disorder (MDD).
Información de AbbVie Inc
Símbolo de cotizaciónABBV
Nombre de la empresaAbbVie Inc
Fecha de salida a bolsaJan 02, 2013
Director ejecutivoMichael (Robert A)
Número de empleados55000
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 02
Dirección1 N Waukegan Rd
CiudadNORTH CHICAGO
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal60064
Teléfono18479327900
Sitio Webhttps://www.abbvie.com/
Símbolo de cotizaciónABBV
Fecha de salida a bolsaJan 02, 2013
Director ejecutivoMichael (Robert A)
Ejecutivos de AbbVie Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Azita Saleki-Gerhardt, Ph.D.
Dr. Azita Saleki-Gerhardt, Ph.D.
Executive Vice President, Chief Operations Officer
Executive Vice President, Chief Operations Officer
204.37K
+0.05%
Mr. Thomas C. (Tom) Freyman, CPA
Mr. Thomas C. (Tom) Freyman, CPA
Independent Director
Independent Director
135.75K
+0.82%
Dr. Roopal Thakkar, M.D.
Dr. Roopal Thakkar, M.D.
Executive Vice President - Research & Development, Chief Scientific Officer
Executive Vice President - Research & Development, Chief Scientific Officer
55.37K
+5.41%
Mr. Edward J. (Ed) Rapp
Mr. Edward J. (Ed) Rapp
Independent Director
Independent Director
45.96K
+2.43%
Ms. Roxanne S. Austin, CPA
Ms. Roxanne S. Austin, CPA
Lead Independent Director
Lead Independent Director
39.58K
+2.82%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
35.65K
--
Mr. Frederick H. (Rick) Waddell
Mr. Frederick H. (Rick) Waddell
Independent Director
Independent Director
30.08K
+3.72%
Ms. Melody B. Meyer
Ms. Melody B. Meyer
Independent Director
Independent Director
17.62K
+6.35%
Mr. Timothy J. Richmond
Mr. Timothy J. Richmond
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
6.13K
-346.66%
Mr. Thomas J. (Tom) Falk
Mr. Thomas J. (Tom) Falk
Independent Director
Independent Director
5.32K
+21.01%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Azita Saleki-Gerhardt, Ph.D.
Dr. Azita Saleki-Gerhardt, Ph.D.
Executive Vice President, Chief Operations Officer
Executive Vice President, Chief Operations Officer
204.37K
+0.05%
Mr. Thomas C. (Tom) Freyman, CPA
Mr. Thomas C. (Tom) Freyman, CPA
Independent Director
Independent Director
135.75K
+0.82%
Dr. Roopal Thakkar, M.D.
Dr. Roopal Thakkar, M.D.
Executive Vice President - Research & Development, Chief Scientific Officer
Executive Vice President - Research & Development, Chief Scientific Officer
55.37K
+5.41%
Mr. Edward J. (Ed) Rapp
Mr. Edward J. (Ed) Rapp
Independent Director
Independent Director
45.96K
+2.43%
Ms. Roxanne S. Austin, CPA
Ms. Roxanne S. Austin, CPA
Lead Independent Director
Lead Independent Director
39.58K
+2.82%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
35.65K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de AbbVie Inc?
Los cinco principales accionistas de AbbVie Inc son: Dr. Azita Saleki-Gerhardt, Ph.D.
¿Cuántas instituciones poseen acciones de AbbVie Inc (ABBV)?
A fecha de 2026Q1, 5703 instituciones poseen acciones de AbbVie Inc, con un valor de mercado combinado de aproximadamente 1.36B, lo que representa el 77.09% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 26641628.00.
¿Cuál es la mayor fuente de ganancias de AbbVie Inc?
El 2026Q1, el segmento empresarial Immunology-SKYRIZI generó la ganancia más alta para AbbVie Inc, ascendiendo a 17.56B y representando el 28.71% de la ganancia total.
